期刊
ACS MEDICINAL CHEMISTRY LETTERS
卷 7, 期 12, 页码 1102-1106出版社
AMER CHEMICAL SOC
DOI: 10.1021/acsmedchemlett.6b00303
关键词
SETDS; HMT; drug design; structure-based drug design; cancer
资金
- U.S. DOE [DE-AC02-06CH11357]
SETD8 is a histone H4-K20 methyltransferase that plays an essential role in the maintenance of genomic integrity during mitosis and in DNA damage repair, making it an intriguing target for cancer research. While some small molecule inhibitors for SETD8 have been reported, the structural binding modes for these inhibitors have not been revealed. Using the complex structure of the substrate peptide bound to SETD8 as a starting point, different natural and unnatural amino acid substitutions were tested, and a potent (K-i 50nM, IC50 0.33 mu M) and selective norleucine containing peptide inhibitor has been obtained.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据